Skip to content

MiNK Therapeutics, Inc.

INKT· NasdaqCore metricsCIK 1840229

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -10.06%
Market cap
$49.82M
5.13M shares
Filings
267
$200.00K
Q3 2026
—
-$2.55M
Q3 2026N/M FY25 yoy
-$2.64M
Q3 2026N/M FY25 yoy
-$5.15M
Q3 2026derivedN/M FY23 yoy
-$0.50
Q3 2026N/M FY25 yoy
$7.47M
Q3 2026+191.9% FY25 yoy
$49.82M
—
—
—
—
—

FY2025 figures · derived

Price

$9.7128.95%$3.96past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$200.00KQ3 2026
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Biological products, except diagnostic substances

MiNK Therapeutics, Inc. is the 124th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

MiNK Therapeutics, Inc. · CIK 1840229 · Engraved from SEC EDGAR